Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Mebeverin (ATC A03AA04).
The work
Conclusion of a non-exclusive discount contract for the drug Mebeverin (ATC A03AA04) from 01.05.2025 to 30.04.2027.
- Contract must be for Mebeverin (ATC A03AA04).
- Contract must be non-exclusive.
- Contract must be concluded within the open-house model.
Key facts
- Contract period
- 24 months
- Evaluation
- This is a contract conclusion process, not a public procurement tender.
What it takes to qualify
Worth a closer look
- The tender document states it is not a public procurement in the sense of Directive 2014/24/EU, which may imply a different submission process.
- The exact submission mode (online/offline) is not specified.
Experience
- At least 1 similar work — Prior experience with pharmaceutical discount contracts is implied by the requirement to be a 'pharmazeutischer Unternehmer'.
- Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not stated in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documentsApplicants must request and submit the contract documents.